PATENT CLAIM ANALYSIS

Application Number: 15915318
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "006900"]

Abstract:
The present invention relates to a pharmaceutical composition comprising complement split product C4d for use in treating an inflammatory condition, such as graft rejection, graft versus host disease, an autoimmune disease or atopy. The C4d to be used may be a multimer. Accordingly, also C4d multimers and their use in medicine, like the treatment of inflammatory conditions, is provided. Furthermore, the present invention provides a protein complex comprising C4d interacting with its ILT4 receptor. This protein complex may be used in screening methods Also antibodies specifically binding to the C4d multimer or the C4d/ILT4-protein complex are subject of the present invention.

Claim (Index 49):
The pharmaceutical composition of  claim 48 , wherein the multimer is a homo-multimer.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.66176
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14412449', '13380659', '15542060', '12186065', '12457444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7606177169566717
- 35 USC 102 Novelty (BERT): 0.6261945894054836
- Combined Prediction Score: 0.7471754042015528
- Mean Citation Score: 349.0565180000001
- Max Citation Score: 731.38513
- Similarity Product: 498.4112096521068

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test